Galmed Pharmaceuticals Ltdis A Clinical Stage Biopharmaceutical Company Based In Ramat Ganisraelfounded In 2000 By Tuvia Gilat And Allen Baharaffthe Company Specializes In Developing Therapeutics For Livermetabolicand Inflammatory Diseaseswith A Small Team Of Approximately Six Employeesgalmed Is Dedicated To Advancing Innovative Drug Candidates Through Clinical Trials The Company S Key Productaramcholis A First In Class Synthetic Fatty Acid Bile Acid Conjugate Molecule Currently In Phase Iii Trials For Non Alcoholic Steatohepatitisnashin Overweight And Obese Patientsadditionallygalmed Is Developing Amilo 5Mera Synthetic Peptide For Inflammatory Conditionsand Mybioticsa Pre Clinical Program Targeting Nash And Fibrosis Through Microbiome Modulationgalmed Collaborates With Partners Like Samil Pharma For Aramchol S Commercialization In South Korea And Onkai To Leverage Ai In Drug Development
